Welcome to the upgraded BRAC University Institutional Repository. We are currently organizing collections after a recent system upgrade. Homepage category counters may temporarily show lower numbers while syncing, but over 27,000 repository items remain safe and accessible. Please use the search bar to find theses, scholarly outputs, and institutional documents.

Drug repurposing in NCDs: benefits and challenges

Thumbnail Image

Files

17146047_PHR.pdf (1.16 MB)

Date

2021-04

Publisher

BRAC University

Authors

Full item page

URI

http://hdl.handle.net/10361/15764

Citation

Abstract

This review focuses on repurposing of drugs for the treatment of noncommunicable diseases. Drug repurposing is the development of new indications for existing drugs. Noncommunicable diseases are causing large number of deaths every year. Therefore, drug repurposing is an effective strategy for the treatment of noncommunicable diseases. This review discusses the methods, benefits and challenges of drug repurposing as well as all the approved repurposed drugs for NCDs and the repurposed drugs that are awaiting approval by the FDA. Considering the challenges faced due to repurposing of drugs, some recommendations are put forward to improve the future of drug repurposing.

Keywords

Drug repurposing, Noncommunicable disease, Market and data exclusivity, Benefits and challenges

LC Subject Headings

Communicable diseases, Chronic diseases--Treatment, Drug development

Description

Cataloged from PDF version of thesis report.
Includes bibliographical references (pages 34-49).
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Publisher Link

Department

Department of Pharmacy

Type

Thesis

Collections

Project report & Thesis (Bachelor of Pharmacy)